Literature DB >> 11186995

Absolute quantification of high energy phosphate metabolites in normal, hypertrophied and failing human myocardium.

S Neubauer1, M Beer, W Landschütz, J Sandstede, T Seyfarth, C Lipke, H Köstler, W Pabst TKenn, M Meininger, M von Kienlin, M Horn, K Harre, D Hahn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11186995     DOI： 10.1007/bf02678501

Source DB:  PubMed          Journal:  MAGMA        ISSN： 0968-5243            Impact factor:   2.310


× No keyword cloud information.
  9 in total

1.  Myocardial adenine nucleotide concentrations and myocardial norepinephrine content in patients with heart failure secondary to idiopathic dilated or ischemic cardiomyopathy.

Authors:  V Regitz; E Fleck
Journal:  Am J Cardiol       Date:  1992-06-15       Impact factor: 2.778

2.  Human cardiac high-energy phosphate metabolite concentrations by 1D-resolved NMR spectroscopy.

Authors:  P A Bottomley; E Atalar; R G Weiss
Journal:  Magn Reson Med       Date:  1996-05       Impact factor: 4.668

3.  Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy.

Authors:  M A Conway; J Allis; R Ouwerkerk; T Niioka; B Rajagopalan; G K Radda
Journal:  Lancet       Date:  1991-10-19       Impact factor: 79.321

4.  Concentrations of human cardiac phosphorus metabolites determined by SLOOP 31P NMR spectroscopy.

Authors:  M Meininger; W Landschütz; M Beer; T Seyfarth; M Horn; T Pabst; A Haase; D Hahn; S Neubauer; M von Kienlin
Journal:  Magn Reson Med       Date:  1999-04       Impact factor: 4.668

5.  Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.

Authors:  S Neubauer; M Horn; M Cramer; K Harre; J B Newell; W Peters; T Pabst; G Ertl; D Hahn; J S Ingwall; K Kochsiek
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

6.  Phosphate metabolite imaging and concentration measurements in human heart by nuclear magnetic resonance.

Authors:  P A Bottomley; C J Hardy; P B Roemer
Journal:  Magn Reson Med       Date:  1990-06       Impact factor: 4.668

7.  31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.

Authors:  S Neubauer; T Krahe; R Schindler; M Horn; H Hillenbrand; C Entzeroth; H Mader; E P Kromer; G A Riegger; K Lackner
Journal:  Circulation       Date:  1992-12       Impact factor: 29.690

8.  Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy.

Authors:  C J Hardy; R G Weiss; P A Bottomley; G Gerstenblith
Journal:  Am Heart J       Date:  1991-09       Impact factor: 4.749

9.  Contributions of 31P-magnetic resonance spectroscopy to the understanding of dilated heart muscle disease.

Authors:  S Neubauer; M Horn; T Pabst; M Gödde; D Lübke; B Jilling; D Hahn; G Ertl
Journal:  Eur Heart J       Date:  1995-12       Impact factor: 29.983
  9 in total
  5 in total

1.  A technique for in vivo mapping of myocardial creatine kinase metabolism.

Authors:  Mohammad Haris; Anup Singh; Kejia Cai; Feliks Kogan; Jeremy McGarvey; Catherine Debrosse; Gerald A Zsido; Walter R T Witschey; Kevin Koomalsingh; James J Pilla; Julio A Chirinos; Victor A Ferrari; Joseph H Gorman; Hari Hariharan; Robert C Gorman; Ravinder Reddy
Journal:  Nat Med       Date:  2014-01-12       Impact factor: 53.440

2.  An improved isolation procedure for adult mouse cardiomyocytes.

Authors:  Ilka Pinz; Ming Zhu; Ulrike Mende; Joanne S Ingwall
Journal:  Cell Biochem Biophys       Date:  2011-09       Impact factor: 2.194

3.  Abnormal energetics and ATP depletion in pressure-overload mouse hearts: in vivo high-energy phosphate concentration measures by noninvasive magnetic resonance.

Authors:  Ashish Gupta; V P Chacko; Robert G Weiss
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-15       Impact factor: 4.733

4.  Amplified detection of phosphocreatine and creatine after supplementation using CEST MRI at high and ultrahigh magnetic fields.

Authors:  KowsalyaDevi Pavuluri; Jens T Rosenberg; Shannon Helsper; Shaowei Bo; Michael T McMahon
Journal:  J Magn Reson       Date:  2020-02-27       Impact factor: 2.229

5.  In Vivo Cannulation Methods for Cardiomyocytes Isolation from Heart Disease Models.

Authors:  Zhong Jian; Yi-Je Chen; Rafael Shimkunas; Yuwen Jian; Mark Jaradeh; Karen Chavez; Nipavan Chiamvimonvat; Jil C Tardiff; Leighton T Izu; Robert S Ross; Ye Chen-Izu
Journal:  PLoS One       Date:  2016-08-08       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.